0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cannabinoids"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Medical Marijuana - Cannabidiol - Pipeline Insight, 2025 - Product Thumbnail Image

Medical Marijuana - Cannabidiol - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,500USDGBP
Chronic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Opioid Dependence- Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Dependence- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Advanced Cancer Pain Management - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$4,750USDGBP
Legal Marijuana Market Report and Forecast 2025-2034 - Product Thumbnail Image

Legal Marijuana Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
Legal Cannabis Market 2025-2029 - Product Thumbnail Image

Legal Cannabis Market 2025-2029

  • Report
  • February 2025
  • 211 Pages
  • Global
From
EUR$2,500USDGBP
Marijuana Market 2024-2028 - Product Thumbnail Image

Marijuana Market 2024-2028

  • Report
  • August 2024
  • 167 Pages
  • Global
From
EUR$2,500USDGBP
The World Market for Cannabis - Product Thumbnail Image

The World Market for Cannabis

  • Report
  • May 2025
  • 46 Pages
  • Global
From
EUR$1,636USDGBP
Top Five Trends in Cannabis - Product Thumbnail Image

Top Five Trends in Cannabis

  • Report
  • April 2025
  • 32 Pages
  • Global
From
EUR$1,636USDGBP
World Market for Cannabis - Product Thumbnail Image

World Market for Cannabis

  • Report
  • August 2024
  • 61 Pages
  • Global
From
EUR$1,636USDGBP
From
EUR$2,490USDGBP
From
EUR$3,869USDGBP
Cannabis in the US - Product Thumbnail Image

Cannabis in the US

  • Report
  • January 2025
  • 42 Pages
  • United States
From
EUR$2,068USDGBP
Intoxicating Hemp-derived Cannabinoids in the U.S. Market - Product Thumbnail Image

Intoxicating Hemp-derived Cannabinoids in the U.S. Market

  • Report
  • July 2024
  • 22 Pages
  • United States
EUR$2,299USDGBP
Latin America CBD and Cannabis Regulatory Bundle - Product Thumbnail Image

Latin America CBD and Cannabis Regulatory Bundle

  • Report
  • January 2024
  • 65 Pages
  • Latin America
EUR$2,588USDGBP
Loading Indicator

The Cannabinoids market, within the context of analgesics, refers to the range of products derived from the cannabis plant that are used for their pain-relieving properties. These substances interact with the body's endocannabinoid system to help alleviate both acute and chronic pain. The market encompasses a variety of cannabinoids, with tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most well-known and extensively studied. These compounds are available in several forms, including oils, tinctures, edibles, patches, and pills, and are recommended for a range of conditions, such as neuropathic pain, inflammation, and muscle soreness. With the evolving legal landscape and growing acceptance of medical cannabis in many regions, the role of cannabinoids as analgesics continues to develop, and their use is being increasingly integrated into pain management protocols. Some companies that have a notable presence in the cannabinoid analgesics market include GW Pharmaceuticals, which is well-known for its cannabinoid-based prescription medicines; Canopy Growth Corporation, a diversified cannabis and cannabinoid-based consumer product company; Tilray, which engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids; and Aurora Cannabis, which specializes in the production and distribution of medical cannabis. Each of these companies focuses on leveraging the therapeutic potential of cannabinoids and developing a range of products aimed at improving patient outcomes in pain management. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more